Selected research
Industry Research
Midazolam Injection Industry Research Report 2026
Market perspective
The global Midazolam Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Midazolam Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Midazolam Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Midazolam Injection include Yichang Humanwell Pharmaceutical, Sandoz, Jiangsu Nhwa Group, Pfizer, Fresenius Kabi, Sun Pharmaceutical, Hikma, Hameln Pharma and Avet Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Midazolam Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Midazolam Injection Market by Company
Yichang Humanwell Pharmaceutical
Sandoz
Jiangsu Nhwa Group
Pfizer
Fresenius Kabi
Sun Pharmaceutical
Hikma
Hameln Pharma
Avet Pharmaceuticals
Athenex
Akorn
Midazolam Injection Segment by Type
1mg/ml
5mg/ml
Midazolam Injection Segment by Application
Recovery Center
Hospital
Clinics
Midazolam Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midazolam Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Midazolam Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midazolam Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Midazolam Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Midazolam Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Midazolam Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg/ml
- 5mg/ml
Applications
- Recovery Center
- Hospital
- Clinics
Companies covered
- Yichang Humanwell Pharmaceutical
- Sandoz
- Jiangsu Nhwa Group
- Pfizer
- Fresenius Kabi
- Sun Pharmaceutical
- Hikma
- Hameln Pharma
- Avet Pharmaceuticals
- Athenex
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Midazolam Injection Market Size (2021-2032)
- 2.2.2 Global Midazolam Injection Sales (2021-2032)
- 2.2.3 Global Midazolam Injection Market Average Price (2021-2032)
- 2.3 Midazolam Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg/ml
- 2.3.3 5mg/ml
- 2.4 Midazolam Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recovery Center
- 2.4.3 Hospital
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Midazolam Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Midazolam Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Midazolam Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Midazolam Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Midazolam Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Midazolam Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Midazolam Injection, Product Type & Application
- 3.8 Global Manufacturers of Midazolam Injection, Established Date
- 3.9 Global Midazolam Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yichang Humanwell Pharmaceutical
- 4.1.1 Yichang Humanwell Pharmaceutical Company Information
- 4.1.2 Yichang Humanwell Pharmaceutical Business Overview
- 4.1.3 Yichang Humanwell Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio
- 4.1.5 Yichang Humanwell Pharmaceutical Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Midazolam Injection Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Jiangsu Nhwa Group
- 4.3.1 Jiangsu Nhwa Group Company Information
- 4.3.2 Jiangsu Nhwa Group Business Overview
- 4.3.3 Jiangsu Nhwa Group Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Nhwa Group Midazolam Injection Product Portfolio
- 4.3.5 Jiangsu Nhwa Group Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Midazolam Injection Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Fresenius Kabi
- 4.5.1 Fresenius Kabi Company Information
- 4.5.2 Fresenius Kabi Business Overview
- 4.5.3 Fresenius Kabi Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius Kabi Midazolam Injection Product Portfolio
- 4.5.5 Fresenius Kabi Recent Developments
- 4.6 Sun Pharmaceutical
- 4.6.1 Sun Pharmaceutical Company Information
- 4.6.2 Sun Pharmaceutical Business Overview
- 4.6.3 Sun Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharmaceutical Midazolam Injection Product Portfolio
- 4.6.5 Sun Pharmaceutical Recent Developments
- 4.7 Hikma
- 4.7.1 Hikma Company Information
- 4.7.2 Hikma Business Overview
- 4.7.3 Hikma Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Midazolam Injection Product Portfolio
- 4.7.5 Hikma Recent Developments
- 4.8 Hameln Pharma
- 4.8.1 Hameln Pharma Company Information
- 4.8.2 Hameln Pharma Business Overview
- 4.8.3 Hameln Pharma Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hameln Pharma Midazolam Injection Product Portfolio
- 4.8.5 Hameln Pharma Recent Developments
- 4.9 Avet Pharmaceuticals
- 4.9.1 Avet Pharmaceuticals Company Information
- 4.9.2 Avet Pharmaceuticals Business Overview
- 4.9.3 Avet Pharmaceuticals Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Avet Pharmaceuticals Midazolam Injection Product Portfolio
- 4.9.5 Avet Pharmaceuticals Recent Developments
- 4.10 Athenex
- 4.10.1 Athenex Company Information
- 4.10.2 Athenex Business Overview
- 4.10.3 Athenex Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Athenex Midazolam Injection Product Portfolio
- 4.10.5 Athenex Recent Developments
- 4.11 Akorn
- 4.11.1 Akorn Company Information
- 4.11.2 Akorn Business Overview
- 4.11.3 Akorn Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Akorn Midazolam Injection Product Portfolio
- 4.11.5 Akorn Recent Developments
5 Global Midazolam Injection Market Scenario by Region
- 5.1 Global Midazolam Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Midazolam Injection Sales by Region: 2021-2032
- 5.2.1 Global Midazolam Injection Sales by Region: 2021-2026
- 5.2.2 Global Midazolam Injection Sales by Region: 2027-2032
- 5.3 Global Midazolam Injection Revenue by Region: 2021-2032
- 5.3.1 Global Midazolam Injection Revenue by Region: 2021-2026
- 5.3.2 Global Midazolam Injection Revenue by Region: 2027-2032
- 5.4 North America Midazolam Injection Market Facts & Figures by Country
- 5.4.1 North America Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Midazolam Injection Sales by Country (2021-2032)
- 5.4.3 North America Midazolam Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Midazolam Injection Market Facts & Figures by Country
- 5.5.1 Europe Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Midazolam Injection Sales by Country (2021-2032)
- 5.5.3 Europe Midazolam Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Midazolam Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Midazolam Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Midazolam Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Midazolam Injection Market Facts & Figures by Country
- 5.7.1 South America Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Midazolam Injection Sales by Country (2021-2032)
- 5.7.3 South America Midazolam Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Midazolam Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Midazolam Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Midazolam Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Midazolam Injection Sales by Type (2021-2032)
- 6.1.1 Global Midazolam Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Midazolam Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Midazolam Injection Revenue by Type (2021-2032)
- 6.2.1 Global Midazolam Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Midazolam Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Midazolam Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Midazolam Injection Sales by Application (2021-2032)
- 7.1.1 Global Midazolam Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Midazolam Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Midazolam Injection Revenue by Application (2021-2032)
- 7.2.1 Global Midazolam Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Midazolam Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Midazolam Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Midazolam Injection Value Chain Analysis
- 8.1.1 Midazolam Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Midazolam Injection Production Mode & Process
- 8.2 Midazolam Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Midazolam Injection Distributors
- 8.2.3 Midazolam Injection Customers
9 Global Midazolam Injection Analyzing Market Dynamics
- 9.1 Midazolam Injection Industry Trends
- 9.2 Midazolam Injection Industry Drivers
- 9.3 Midazolam Injection Industry Opportunities and Challenges
- 9.4 Midazolam Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst